- Home
- DGX vs SSNC Comparison
DGX vs SSNC Comparison
Compare DGX & SSNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGX
- SSNC
- Stock Information
- Founded
- DGX 1967
- SSNC 1986
- Country
- DGX United States
- SSNC United States
- Employees
- DGX N/A
- SSNC N/A
- Industry
- DGX Medical Specialities
- SSNC EDP Services
- Sector
- DGX Health Care
- SSNC Technology
- Exchange
- DGX Nasdaq
- SSNC Nasdaq
- Market Cap
- DGX 20.5B
- SSNC 21.7B
- IPO Year
- DGX 1996
- SSNC 1996
- Fundamental
- Price
- DGX $180.17
- SSNC $88.46
- Analyst Decision
- DGX Buy
- SSNC Strong Buy
- Analyst Count
- DGX 15
- SSNC 8
- Target Price
- DGX $185.40
- SSNC $97.38
- AVG Volume (30 Days)
- DGX 692.9K
- SSNC 984.5K
- Earning Date
- DGX 10-21-2025
- SSNC 10-23-2025
- Dividend Yield
- DGX 1.77%
- SSNC 1.13%
- EPS Growth
- DGX 12.66
- SSNC 14.31
- EPS
- DGX 8.35
- SSNC 3.17
- Revenue
- DGX $10,522,000,000.00
- SSNC $6,046,200,000.00
- Revenue This Year
- DGX $11.12
- SSNC $7.75
- Revenue Next Year
- DGX $3.41
- SSNC $5.10
- P/E Ratio
- DGX $21.63
- SSNC $27.88
- Revenue Growth
- DGX 12.58
- SSNC 6.75
- 52 Week Low
- DGX $146.17
- SSNC $66.83
- 52 Week High
- DGX $185.62
- SSNC $91.07
- Technical
- Relative Strength Index (RSI)
- DGX 51.80
- SSNC 51.91
- Support Level
- DGX N/A
- SSNC N/A
- Resistance Level
- DGX $185.05
- SSNC $90.26
- Average True Range (ATR)
- DGX 2.38
- SSNC 1.38
- MACD
- DGX -6.91
- SSNC -3.40
- Stochastic Oscillator
- DGX 97.36
- SSNC 98.01
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
About SSNC SS&C Technologies Holdings Inc.
SS&C Technologies provides software products and software-enabled services to a variety of customers primarily in financial services but also healthcare firms. Acquisitions are a large part of SS&C's history. SS&C GlobeOp provides fund administration services to alternative and traditional asset managers. In addition, SS&C provides portfolio accounting, portfolio management, trading, banking/lending, and other software to asset managers, banks, and financial advisors. SS&C's purchase of Intralinks makes it a leading player in virtual deal room solutions. With its 2018 purchase of DST Systems, SS&C gained a foothold in the healthcare industry with pharmacy health management solutions and medical claim administration services. In 2022, SS&C completed the acquisition of Blue Prism.